Lipocine Inc (LPCN)

Overview News Price History Financials Discussions Forecast Stock Split

Lipocine Inc Stock (LPCN) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	3,423% 7.6172	0.2162	-3.122	-	0.055
Operating Expenses	56.42% 4.3946	2.8095	3.9214	3.9556	4.3936
Benefits Costs and Expenses	64.27% 4.1034	2.4979	3.529	3.5486	3.925
Costs And Expenses	233.63% 4.1034	1.2299	3.9214	3.9556	4.3936
Depreciation and Amortization	6.36% 0.00851	0.008	0.00775	0.00809	0.00482
Operating Income/Loss	224.26% 3.2225	-2.5934	-7.0434	-3.9556	-4.3386
Nonoperating Income/Loss	6.53% 0.2913	0.3117	0.3924	0.407	0.4686
Income/Loss From Continuing Operations Before Tax	254.00% 3.5138	-2.2817	-6.651	-3.5486	-3.87
Income Tax Expense/Benefit	0.0002	-	-	-	0.0002
Income/Loss From Continuing Operations After Tax	253.94% 3.5136	-2.2825	-6.651	-3.5486	-3.8702
Net Income/Loss	253.95% 3.5136	-2.2823	-6.651	-3.5486	-3.8702
Preferred Stock Dividends And Other Adjustments	-	-	-	-	0.000089
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34,074% 5.3158	0.0156	5.2921	5.2348	88.51
Diluted Average Shares	34,342% 5.3575	0.0156	5.2921	5.2348	88.51
Basic Earnings Per Share	257.14% 0.66	-0.42	-1.26	-0.68	-0.04
Diluted Earnings Per Share	257.14% 0.66	-0.42	-1.27	-0.68	-0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	0.000089

GMAB

$21.50

1.61%

INCY

$74.59

1.14%

UTHR

$370.49

2.02%

MRNA

$43.06

0.76%

BGNE

$215.00

4.29%

BNTX

$118.39

1.93%